Vincent J. Angotti

2017

In 2017, Vincent J. Angotti earned a total compensation of $2.4M as Chief Executive Officer at AcelRx Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$164,340
Option Awards$1,687,122
Salary$493,461
Other$9,000
Total$2,353,923

Angotti received $1.7M in option awards, accounting for 72% of the total pay in 2017.

Angotti also received $164.3K in non-equity incentive plan, $493.5K in salary and $9K in other compensation.

Rankings

In 2017, Vincent J. Angotti's compensation ranked 4,717th out of 14,666 executives tracked by ExecPay. In other words, Angotti earned more than 67.8% of executives.

ClassificationRankingPercentile
All
4,717
out of 14,666
68th
Division
Manufacturing
1,666
out of 5,772
71st
Major group
Chemicals And Allied Products
487
out of 2,075
77th
Industry group
Drugs
374
out of 1,731
78th
Industry
Pharmaceutical Preparations
296
out of 1,333
78th
Source: SEC filing on April 23, 2018.

Angotti's colleagues

We found seven more compensation records of executives who worked with Vincent J. Angotti at AcelRx Pharmaceuticals in 2017.

2017

Pamela Palmer

AcelRx Pharmaceuticals

Chief Medical Officer

2017

Howard Rosen

AcelRx Pharmaceuticals

Chief Executive Officer

2017

Raffi Asadorian

AcelRx Pharmaceuticals

Chief Financial Officer

2017

Badri Dasu

AcelRx Pharmaceuticals

Chief Engineering Officer

2017

Lawrence Hamel

AcelRx Pharmaceuticals

Chief Development Officer

2017

Timothy Morris

AcelRx Pharmaceuticals

Chief Financial Officer

2017

Jane Wright-Mitchell

AcelRx Pharmaceuticals

Chief Legal Officer

News

In-depth

You may also like